EP3290421
Samsetning af pyrróló[2,3-d]pýrimídín-afleiðum með einum eða fleiri öðrum miðlum sem hindrum fyrir Janus-tengda kínasa (JAK)
:
EP einkaleyfi í gildi á Íslandi:
11.2.2014:
2.1.2019:
17191163.9
:
4.2.2019:
15.2.2019
:
10.2.2034:
10.2.2026:
28.2.2026
:
COMBINATION OF PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES WITH ONE OR MORE ADDITIONAL AGENTS AS INHIBITORS OF JANUS- RELATED KINASES (JAK)
11.2.2014
2.1.2019
4.2.2019
15.2.2019
10.2.2026
:
Pfizer Inc.:
66 Hudson Boulevard East, New York, NY 10001-2192, US
:
BROWN, Matthew Frank:
Stonington, CT Connecticut, US
:
FENWICK, Ashley Edward:
Richland, MI Michigan, US
:
FLANAGAN, Mark Edward:
Gales Ferry, CT Connecticut, US
:
GONZALES, Andrea:
Kalamazoo, MI Michigan, US
:
JOHNSON, Timothy Allan:
Richland, MI Michigan, US
:
KAILA, Neelu:
Lexington, MA Massachusetts, US
:
MITTON-FRY, Mark J.:
Granville, OH Ohio, US
:
STROHBACH, Joseph Walter:
Wentzville, MO Missouri, US
:
TENBRINK, Ruth E.:
Labadie, MO Missouri, US
:
TRZUPEK, John David:
Medford, MA Massachusetts, US
:
UNWALLA, Rayomand Jal:
Bedford, MA Massachusetts, US
:
VAZQUEZ, Michael L.:
Billerica, MA Massachusetts, US
:
PARIKH, Mihir, D.:
Groton, MA Massachusetts, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201361767947 P:
22.2.2013:
US
:
C07D 487/04, A61K 31/519, C07D 519/00, A61P 37/00
: 6
: 8.2.2019
: 10.2.2020
: Árnason Faktor
: 7
: 16.1.2020
: 10.2.2021
: Örn Þór
: 8
: 13.1.2021
: 10.2.2022
: Örn Þór slf.
: 9
: 19.1.2022
: 10.2.2023
: Árnason Faktor ehf.
: 10
: 12.1.2023
: 10.2.2024
: Árnason Faktor ehf.
: 11
: 10.1.2024
: 10.2.2025
: Árnason Faktor ehf.
: 12
: 13.1.2025
: 10.2.2026
: Árnason Faktor ehf.